Crispr Therapeutics shares owned by Schroder Investment Management Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Schroder Investment Management Group
from 13F filings
Historical chart of Schroder Investment Management Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Schroder Investment Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Schroder Investment Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.2M | 23k | 54.01 |
| 2024-03-31 | $1.6M | 23k | 68.16 |
| 2023-12-31 | $1.4M | 23k | 62.60 |
| 2023-09-30 | $5.7M | 125k | 45.39 |
| 2023-06-30 | $7.1M | 127k | 56.14 |
| 2023-03-31 | $1.3M | 28k | 45.23 |
| 2021-09-30 | $2.2M | 20k | 111.63 |
| 2021-06-30 | $2.0M | 12k | 161.29 |
More positions owned by Schroder Investment Management Group
View all positions for Schroder Investment Management Group